林雅婷老師

期刊名稱	源遠護理
資料日期	2012-01-18

[摘要] :
頭頸部癌症病人接受放射線治療後口腔合併症之嚴重度變化

頭頸部癌症病人接受放射治療後，超過70%以上的病人有口腔合併症發生，且隨著放射治療時間逐漸拉長，病人口腔合併症嚴重度亦逐漸上升，致病人感受到中重度的症狀困擾。本文旨在回顧長期性追蹤文獻，運用歐洲癌症研究與治療組織之頭頸部位特殊性量表，探討頭頸部癌症病人接受放射治療後口腔合併症嚴重度，在不同放射治療時間點的變化。文獻整理結果為病人在放射治療後第二到三個月時，口腔合併症嚴重度最為嚴重，其中口腔疼痛與吞嚥困難嚴重度，分別在放射治療後半年至三年後緩解到治療前狀態，但在接受放射治療後三年，病人口乾、唾液黏稠與味覺改變嚴重度，卻仍高於接受放射治療前。因此頭頸部癌症病人在放射治療第一到三個月間，即面臨口腔合併症的干擾，而改善病人的不適症狀一向是醫護人員之首要任務，醫療團隊要妥善地認知，病人因放射治療導致口腔合併症的身心不適、社會壓力，進而提供病人更深層與全面性的照顧，以達到全人照顧的理想境界。
關鍵詞：口腔合併症、放射治療、頭頸部癌症

[英文摘要] :
More than 70% of the patients with head and neck cancer will suffer from oral complications after receiving radiotherapy. In addition, with the extension in treatment time, the severity of patients’ oral complications increases as well. As a result, the patients will be tormented by moderate to severe symptoms. This paper reviews the literature on long-term follow-up, and uses the Head Neck Module Questionnaire of European Organization for Research and Treatment of Cancer (EORTC H&N35) to investigate the changes in severity of oral complications in patients with head and neck cancers at different stages in the radiotherapy treatment. The results indicate that the patients would suffer from the highest level severity of oral complications within 2-3 months after receiving radiotherapy. Among the symptoms of oral complications, oral pain and dysphagia are alleviated to the pre-treatment state after receiving radiotherapy for 6 months to 3 years, However, after receiving the treatment for three years, the severity of thirst, sticky saliva, and dysgeusia are still higher than that before receiving the treatment. Therefore, the patients with head and neck cancers immediately suffer from oral complications at the stage from Month 1 to Month 3 after receiving radiotherapy. Since improving the symptoms of patients has always been the top priority of medical staff, medical teams should properly understand physical and psychological discomfort and social pressures of patients, and further provide them with closer and more comprehensive care to achieve the purpose of holistic care.

Key words: oral complications, radiotherapy, head and neck cancer

[參考文獻] :
衛生署（2009，10月1日）．97 ICD10死因摘要．2010年1月12日取自http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx?now_fod_list_no=10642&class_no=440&level_no=3
衛生署（2010，1月7日）．97年衛生統計動向．2010年1月12日取自http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx?now_fod_list_no=10987&class_no=440&level_no=2
Bansal, M., Mohanti, B. K., Shah, N., Chaudhry, R., Bahadur, S., & Shukla, N. K. (2004). Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Quality of Life Research, 13(2), 481-488.
Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J. F., Biorklund, A., et al. (2001). A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope, 111(8), 1440-1452.
Browman, G. P., Levine, M. N., Hodson, D. I., Sathya, J., Russell, R., Skingley, P., et al. (1993). The Head and Neck Radiotherapy Questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. Journal of Clinical Oncology, 11(5), 863-872.
DeGraeff, A., DeLeeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. M. (1999). A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncology, 35(1), 27-32.
DeGraeff, A., DeLeeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. M. (2000a). Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head and Neck, 22(4), 398-407.
DeGraeff, A., DeLeeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. M. (2000b). Long-term quality of life of patients with head and neck cancer. Laryngoscope, 110(1), 98-106.
Dirix, P., Nuyts, S., & Van den Bogaert, W. (2006). Radiation-induced xerostomia in patients with head and neck cancer: A literature review. Cancer, 107(11), 2525-2534.
Dirix, P., Nuyts, S., Vander Poorten, V., Delaere, P., & Van den Bogaert, W. (2007). The influence of xerostomia after radiotherapy on quality of life : Results of a questionnaire in head and neck cancer. Supportive Care in Cancer, 16(2), 171-179.
Duncan, G. G., Epstein., J. B., Tu, D., Sayed, S. E., Bezjak, A., Ottaway, J., et al. (2005). Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancer: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head and Neck, 27(5), 421-428.
Elting, L. S., Cooksley, C. D., Chambers, M. S., & Garden, A. S. (2007). Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. International Journal of Radiation Oncology, Biology, Physics, 68(4), 1110-1120.
Epstein, J. B., Emerton, S., Kolbinson, D. A., Le, N. D., Phillips, N., Stevenson-Moore, P., et al. (1999). Quality of life and oral function following radiotherapy for head and neck cancer. Head and Neck, 21(1), 1-11.
Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Jannert, M., Kaasa, S., Sullivan, M., et al. (1997). Prospective, longitudinal quality-of-life study of patients with head and neck cancer: A feasibility study including the EORTC QLQ-C30. Archives of Otolaryngology - Head and Neck Surgery, 116(1), 666-673.
Hammerlid, E., Mercke, C., Sullivan, M., & Westin, T. (1997). A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy. Oral Oncology, 33(3), 189-196.
Hammerlid, E., Silander, E., Hörnestam, L., & Sullivan, M. (2001). Health-related quality of life three years after diagnosis of head and neck cancer--a longitudinal study. Head and Neck, 23(2), 113-125.
Harrison, L. B., Zelefsky, M. J., Pfister, D. G., Carper, E., Raben, A., Kraus, D. H., et al. (1997). Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head and Neck, 19(3), 169-175.
Huguenin, P., Beer, K. T., Allal, A., Rufibach, K., Friedli, C., Davis, J. B., et al. (2004). Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. Journal of Clinical Oncology, 22(23), 4665-4673.
Jellema, A. P., Slotman, B. J., Muller, M. J., Leemans, C. R., Smeele, L. E., Hoekman, K., et al. (2006). Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer. Cancer, 107(3), 544-553.
Lai, Y. H., Chang, J. T., Keefe, F. J., Chiou, C. F., Chen, S. C., Feng, S. C., et al. (2003). Symptom distress, catastrophic thinking, and hope in nasopharyngeal carcinoma patients. Cancer Nursing, 26(6), 485-493.
Maes, A., Huygh, I., Weltens, C., Vandevelde, G., Delaere, P., Evers, G., et al. (2002). De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy. Radiotherapy and Oncology, 63(2), 195-201.
Nicolatou-Galitis, O., Sotiropoulou-Lontou, A., Velegraki, A., Pissakas, G., Kolitsi, G., Kyprianou, K., et al. (2003). Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. Oral Oncology, 39(4), 397-401.
Osoba, D. (2007). Translating the science of patient-reported outcomes assessment into clinical practice. Journal of the National Cancer Institute Monographs(37), 5-11.
Petruson, K., Mercke, C., Lundberg, L. M., Silander, E., & Hammerlid, E. (2005). Longitudinal evaluation of patients with cancer in the oral tongue, tonsils, or base of tongue-Does interstitial radiation dose affect quality of life? Brachytherapy, 4(4), 271-277.
Saarilahti, K., Kouri, M., Collan, J., Hamalainen, T., Atula, T., Joensuu, H., et al. (2005). Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiotherapy and Oncology, 74(3), 251-258.
Semple, C. J., Dunwoody, L., George Kernohan, W., McCaughan, E., & Sullivan, K. (2008). Changes and challenges to patients' lifestyle patterns following treatment for head and neck cancer. Journal of Advanced Nursing, 63(1), 85-93.
Shi, H. B., Masuda, M., Umezaki, T., Kuratomi, Y., Kumamoto, Y., Yamamoto, T., et al. (2004). Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx, 31(4), 401-406.
Shih, A., Miaskowski, C., Dodd, M. J., Stotts, N. A., & Macphail, L. (2003). Mechanisms for radiation-induced oral mucositis and the consequences. Cancer Nursing, 26(3), 222-229.
Specht, L. (2002). Oral complications in the head and neck radiation patient. Introduction and scope of the problem. Supportive Care in Cancer, 10(1), 36-39.
Sprinzl, G. M., Galvan, O., de Vries, A., Ulmer, H., Gunkel, A. R., Lukas, P., et al. (2001). Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. European Journal of Cancer, 37(16), 2003-2009.
Trotti, A., Bellm, L. A., Epstein, J. B., Frame, D., Fuchs, H. J., Gwede, C. K., et al. (2003). Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology, 66(3), 253-262.
Vissink, A., Burlage, F. R., Spijkervet, F. K., Jansma, J., & Coppes, R. P. (2003). Prevention and treatment of the consequences of head and neck radiotherapy. Critical Reviews in Oral Biology and Medicine, 14(3), 213-225.
.